Advances in Hepatology
World Congress on Hepatitis
July 20-22, 2015 Orlando, Florida, USA

Maxwell M Chait

Scientific Tracks Abstracts: J Liver

Abstract:

The field of hepatology has had major advances in the evaluation and management of liver disease. The burden of liver disease worldwide depends on essentially on the incidence of cirrhosis and hepatocellular carcinoma. The major factors causing cirrhosis are alcoholic liver disease (ALD), hepatitis B and C and nonalcoholic liver disease (NAFLD). Effective therapies for hepatitis B and C have been developed that continue to evolve with remarkable success. ALD remains a major health problem and NAFLD has become a health problem of epidemic proportions. Abstinence from alcohol and reduction in obesity are the major preventative strategies for theses illnesses. Approaches continue to be developed to manage the complications of cirrhosis and hepatocellular carcinoma. Liver transplantation has evolved to a standard therapy for end-stage liver disease. Reducing the burden of liver disease through prevention, cure and treatment of complications is now possible.

Biography :

Maxwell M Chait completed his MD degree from the University of California School of Medicine at San Francisco. He is a Fellow of several prestigious organizations, including the American College of Physicians, American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a practicing gastroenterologist in the faculty of the Columbia University College of Physicians and Surgeons. He has authored numerous publications and serves on the editorial board of the World Journal of Gastrointestinal Endoscopy and the Journal of Liver Disease and Transplantation Biology.